Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study
Open Access
- 1 November 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (11) , 874-879
- https://doi.org/10.1111/j.1469-0691.2005.01256.x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Clinical Features and Epidemiology of Acinetobacter baumannii Colonization and Infection in Spanish HospitalsInfection Control, 2004
- Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish HospitalsAntimicrobial Agents and Chemotherapy, 2004
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York CityClinical Infectious Diseases, 2003
- Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern SpainJournal of Clinical Microbiology, 2002
- Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unitJournal of Hospital Infection, 2002
- Antibiotic Resistance Is a Major Risk Factor for Epidemic Behavior ofAcinetobacter baumanniiInfection Control & Hospital Epidemiology, 2001
- An Outbreak of Imipenem-ResistantAcinetobacter baumanniiin Critically Ill Surgical PatientsInfection Control & Hospital Epidemiology, 2001
- Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic UsageClinical Infectious Diseases, 2000
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988